India vs Iran: Share of E. coli infections resistant to cephalosporins
India
77.5%
in 2022
Iran
70.6%
in 2022
India rank
4th
Iran rank
7th
Share of E. coli infections resistant to cephalosporins over time
- India
- Iran
How they compare
India currently reports 77.5% against 70.6% in Iran, a difference of 6.9%.
That makes India's figure about 1.1 times Iran's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Iran ahead.
India ranks 4th and Iran ranks 7th of 46 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.2% | 75.3% | 3.0% | India |
| 2020s | 80.6% | 70.0% | 10.6% | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, India or Iran?
- India, at 77.5% against 70.6% in Iran as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between India and Iran?
- 6.9%, with India ahead.
- How many years of comparable data are there for India and Iran?
- 6 years are reported by both, from 2017 to 2022.
- How do India and Iran rank globally for share of e. coli infections resistant to cephalosporins?
- India ranks 4th and Iran ranks 7th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).